Effects of aspirin on the levels of hydrogen sulfide and sulfane sulfur in mouse tissues

Pharmacological Reports

Volumn 62, Issue 2, 2010, Pages 304-310

  Bilska, Anna ^a   Iciek, Małgorzata ^a   Kwiecień, Inga ^a,b   Kaniecki, Karol ^a   Paliborek, Magdalena ^a   Somogyi, Eugeniusz ^c   Piotrowska, Joanna ^c   Wiliński, Bogdan ^c   Góralska, Marta ^c   Srebro, Zbigniew ^c   Włodek, Lidia ^a  

^a Chair of Medical Biochemistry   (Poland)

^b Chair and Department of Pharmaceutical Botany   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Aspirin; Glial Gomori positive material; Hydrogen sulfide; Sulfane sulfur

Indexed keywords

ACETYLSALICYLIC ACID; CYSTATHIONINE GAMMA LYASE; HYDROGEN SULFIDE; SULFANE SULFUR; SULFUR DERIVATIVE; THIOSULFATE SULFURTRANSFERASE; UNCLASSIFIED DRUG; CYSTEINE;

AMINO ACID METABOLISM; ANAEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; GLIA CELL; LIVER LEVEL; MOUSE; NONHUMAN; ANIMAL; BRAIN; DRUG EFFECTS; LIVER; METABOLISM;

ANIMALS; ASPIRIN; BRAIN; CYSTEINE; FEMALE; HYDROGEN SULFIDE; LIVER; MICE; SULFUR COMPOUNDS;

EID: 77953306469     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70270-X     Document Type: Article

References (42)

1. Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MM, Hofman A: Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology, 1995, 45, 1441-1445.
2. Belardinelli MC, Chabli A, Chadefaux-Vekemans B, Kamoun P: Urinary sulfur compounds in Down syndrome. Clin Chem, 2001, 47, 1500-1501.
3. Betowski J: Hydrogen sulfide as a biologically active mediator in the cardiovascular system (Polish). Postepy Hig Med Dosw (online), 2004, 58, 285-291.
4. Broe GA, Grayson DA, Creasey HM, Waite LM, Casey BJ, Bennett HP, Brooks WS, Halliday GM: Antiinflammatory drugs protect against Alzheimer disease at low doses. Arch Neurol, 2000, 57, 1586-1591.
5. Buzaleh AM, Vazquez ES, Battle AM: Cyanide intoxication - I. An oral chronic animal model. Gen Pharmacol, 1989, 20, 323-327.
6. Buzaleh AM, Vazquez ES, Battle AM: Cyanide intoxication - II. The effects of systematic cyanide challenge on indicative toxicity parameters. Comp Biochem Physiol, 1990, 96, 177-180.
7. Cronstein BN,Weissmann G: Targets for anti-inflammatory drugs. Annu Rev Pharmacol Toxicol, 1995; 35, 449-462.
8. Czyż M, Watała C: Aspirin - the prodigious panacea? Molecular mechanisms of the action of acetylsalicylic acid in the organism (Polish). Postepy Hig Med Dosw (online), 2005, 59, 105-115.
9. Eto K, Asada T, Arima K, Makifuchi T, Kimura H: Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun, 2002, 293, 1485-1488.
10. Fiorucci S, Antonelli E, Distrutti E, Rizzo G, Mencarelli A, Orlandi S, Zanardo R et al.: Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology, 2005, 129, 1210-1224.
11. Fiorucci S, Distrutti E, Mencarelli A, Rizzo G, Lorenzo AR, Baldoni M, Del Soldato P et al.: Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NOaspirin) on neutrophil-endothelial cell adherence. J Pharmacol Exp Ther, 2004, 309, 1174-1182.
12. Hosoki R, Matsuki N, Kimura H: The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun, 1997, 237, 527-531.
13. Hu LF, Wong PT, Moore PK, Bian JS: Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem, 2007, 100, 1121-1128.
14. Iciek M, Bilska A, Ksia̧dek L, Srebro Z, Włodek L: Allyl disulfide as donor and cyanide as acceptor of sulfane sulfur in the mouse tissues. Pharmacol Rep, 2005, 57, 212-218.
15. Iciek MB, Włodek L: Biosynthesis and biological properties of compounds containing highly reactive reduced sulfane sulfur. Pol J Pharmacol, 2001, 53, 215-225.
16. Kamoun P: Mental retardation in Down syndrome: a hydrogen sulfide hypothesis. Med Hypotheses, 2001, 57, 389-392.
17. 2S) - the third gas of interest for pharmacologists. Pharmacol Rep, 2007, 59, 4-24.
18. Lowry O, Rosebrough NJ, Farr AL, Randal RJ: Protein measurement with the Folin fenol reagent. J Biol Chem, 1951, 193, 265-275.
19. Matsuo Y, Greenberg DM: A crystalline enzyme that cleaves homoserine and cystathionine. I. Isolation procedure and some physicochemical properties. J Biol Chem, 1958, 230, 545-560.
20. McGeer PL, Schulzer M, McGeer EG: Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology, 1996, 47, 425-432.
21. Morgan G: Could vitamin S (salicylate) protect against childhood cancer? Med Hypotheses, 2005, 64, 661.
22. Ogasawara Y, Isoda S, Tanabe S: Tissue and subcellular distribution of bound and acid-labile sulfur and the enzymatic capacity for sulfide production in rat. Biol Pharm Bull, 1994, 418, 379-404.
23. Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, Jeon SB et al.: Hydrogen sulfide inhibits nitric oxide production and nuclear factor-_B via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med, 2006, 41, 106-119.
24. Pearse AG: Histochemistry, Theoretical and Applied. London, Churchill, 1960.
25. Potyk D: Treatments for Alzheimer's disease. South Med J, 2005, 98, 628-635.
26. Rinaldi L, Gobbi G, Pambianco M, Micheloni C, Mirandola P, Vitale M: Hydrogen sulfide prevents apoptosis of human PMN via inhibition of p38 and caspase 3. Lab Incest, 2006, 86, 391-397.
27. Sagone AL Jr, Husney RM: Oxidation of salicylates by stimulated granulocytes: evidence that these drugs act as free radical scavengers in biological systems. J Immunol, 1987, 138, 2177-2183.
28. Schipper HM: Gomori-positive astrocytes: biological properties and implications for neurologic and neuroendocrine disorders. Glia, 1991, 4, 365-377.
29. Siegel LM: A direct microdetermination for sulfide. Anal Biochem, 1965, 11, 126-132.
30. Soda K: A spectrofotometric microdetermination of keto acids with 3-methyl-2-benzothiazolone hydrazone. Agric Biol Chem, 1967, 31, 1054-1060.
31. Só́rbo B: Rhodanese. Methods Enzymol, 1955, 2, 334-337.
32. Srebro Z, Iciek M, Sura P, Góralska M: The glial Gomori-positive material is sulfane sulfur. Folia Histochem Cytobiol, 2008, 46, 1-5.
33. Srebro Z, Lach H: X-ray and UV-induced increase in number of cysteine-rich periventricular glial cells in the brains of rats and mice. Acta Biol Acad Sci Hung, 1972, 23, 145-151.
34. Srebro Z, Somogyi E, Wiliński B, Góralska M, Wiliński J, Sura P: Aspiryn augments the concentration of endogenous hydrogen sulfide in mouse brain and liver. Folia Med Cracov, 2006, 47, 87-91.
35. Sura P, Srebro Z, Wiliński B, Góralska M: The effect of aspiryn on Gomori-positive glia in mouse brain. Folia Biol (Kraków), 2008, 56, 73-75.
36. Toohey JI: Sulphane sulphur in biological systems: a possible regulatory role. Biochem J, 1989, 264, 625-632.
37. correction: Biochem J, 1990, 267, 843.
38. Vane JR, Botting RM: The mechanism of action of aspirin. Thromb Res, 2003, 110, 255-258.
39. Wallace JL: Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol Sci, 2007, 28, 501-505.
40. Whiteman M, Armstrong JS, Chu SH, Jia-Ling S, Wong BS, Cheung NS, Halliwell B, Moore PK: The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J Neurochem., 2004, 90, 765-768.
41. Whiteman M, Rose P, Siau JL, Cheung NS, Tan GS, Halliwell B, Armstrong JS: Hypochlorous acid-mediated mitochondrial dysfunction and apoptosis in human hepatoma HepG2 and human fetal liver cells: role of mitochondrial permeability transition. Free Radic Biol Med, 2005, 38, 1571-1584.
42. Zhong G, Chen F, Cheng Y, Tang C, Du J: The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens, 2003, 21, 1879-1885.